Caddie Laberiano-Fernández

Role of Scientific Societies in Continuing Education in Cytopathology: Present and Future Perspectives

Milagros Abad-Licham, Andrea Gersztein, Cecilia Gimenez, Cioly Rivero Colmenarez et autres

This article analyzes the role of Scientific Medical Societies (SMS) in continuing education in Cytopathology, emphasizing their impact on professional development, diagnostic quality, and patient safety. In recent years, Cytopathology has undergone significant growth driven by technological and molecular advances, which have …

pe, ar, us, lu, co, mx, es, br, it, tw (code pays fourni par la source)

191 Tumor microenvironment changes after treatment with avelumab combinations in patients with advanced solid tumors

Nejla Ozirmak Lermi, Mohamed Alaa Gouda, Jibran Ahmed, Xianli Jiang et autres

Background The use of immune checkpoint inhibitors (ICIs) has led to a paradigm change in cancer management. Many patients may have inherent primary resistance to ICIs or develop secondary resistance after initial response. The impact of using novel therapeutic combinations of checkpoint …

us (code pays fourni par la source)

Evaluating the Global Cytology Program Education Series: A Participant Survey

C.D. Anthony Herndon, Alarice Cheng-Yi Lowe, Glorimar Rivera, Zahra Maleki et autres

us, it, gb (code pays fourni par la source)

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Sandip Pravin Patel, Young Kwang Chae, Luisa M. Solis Soto, Anup Kasi et autres

PURPOSE: umors (DART) studied the efficacy of ipilimumab combined with nivolumab across multiple rare tumor types. We report the results of the pancreatic neuroendocrine neoplasm (PNEN) cohort. EXPERIMENTAL DESIGN: Treatment consisted of ipilimumab 1 mg/kg intravenously every 6 weeks with nivolumab 240 …

us (code pays fourni par la source)

FLASH radiotherapy spares lymphocytes in tumor-draining lymph nodes and increases infiltration of immune cells in tumors

Francisco Sáenz, Brett Velasquez, T. J. Waldrop, Edgardo A Aguilar et autres

Abstract Radiotherapy (RT) delivered at conventional dose rates (CONV) can both stimulate antitumor immune responses and inhibit these immune responses by depleting circulating lymphocytes. Given the observed normal tissue sparing associated with ultra-high dose rate (FLASH) RT, we hypothesized that FLASH RT …

us (code pays fourni par la source)

Standardizing Pre-analytic Factors in Cytology Specimens for ICC Evaluation and Their Assessment Using Image Analysis

Caddie Laberiano-Fernández, Qiong Zhi Gan, Sean Barnes, Mei Jiang et autres

us (code pays fourni par la source)

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

Jeffrey How, Minghao Dang, Sanghoon Lee, Bryan M. Fellman et autres

us (code pays fourni par la source)

Supplementary Figure 6 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin Roger Parra, Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova et autres

Supplementary Figure 6. Immune associations with copy number variants.

Supplementary Figure 7 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin Roger Parra, Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova et autres

Supplementary Figure 7. LRP1B mutation associations with immune infiltration and survival.

Supplementary Figure 2 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin Roger Parra, Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova et autres

Supplementary Figure 2. Spatial organization and cell clustering in exceptional responders.

Supplementary Table 5 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin Roger Parra, Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova et autres

Supplementary Table 5. Overall associations between cell phenotypes by compartment in both arms.

Supplementary Figure 2 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin Roger Parra, Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova et autres

Supplementary Figure 2. Spatial organization and cell clustering in exceptional responders.